| Drug Type Natural Killer Cell Therapies | 
| Synonyms- | 
| Target- | 
| Action- | 
| Mechanism Immunologic cytotoxicity | 
| Therapeutic Areas | 
| Active Indication- | 
| Inactive Indication | 
| Originator Organization | 
| Active Organization- | 
| Inactive Organization | 
| License Organization- | 
| Drug Highest PhasePendingPhase 1 | 
| First Approval Date- | 
| Regulation- | 
| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Neuroblastoma recurrent | Phase 1 | Iran  | 19 Feb 2021 | 





